9. Чаулин А.М., Дупляков Д.В. PCSK-9: современные представления о биологической роли и возможности использования в качестве диагностического маркера сердечно-сосудистых заболеваний. Часть 1 // Кардиология: новости, мнения, обучение. 2019. Т. 7. №2. С. 45-57.
10. Чаулин А.М., Дупляков Д.В. PCSK-9: современные представления о биологической роли и возможности использования в качестве диагностического маркера сердечнососудистых заболеваний. Часть 2 // Кардиология: новости, мнения, обучение. 2019. Т. 7. №4. C. 24-35.
11. Чаулин А.М., Григорьева Ю.В., Суворова Г.Н., Дупляков Д.В. Способы моделирования атеросклероза у кроликов // Современные проблемы науки и образования. 2020. №5.
12. Libby P. Inflammation in atherosclerosis // Nature. 2002. V. 420. №6917. 868-874.
13. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis // Circulation. 2002. V. 105. №9. P. 1135-1143.
14. Mestas J., Ley K. Monocyte-endothelial cell interactions in the development of
atherosclerosis // Trends in cardiovascular medicine. 2008. V. 18. №6. P. 228-232.
15. Rader D.J., Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis // Nature. 2008. V. 451. №7181. P. 904-913.
16. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis // Science. 1991. V. 251. №4995. P. 788-791.
17. Li H., Cybulsky M.I., Gimbrone Jr M.A., & Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma // The American journal of pathology. 1993. V. 143. №6. P. 1551-1559.
18. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptordeficient mice // Molecular cell. 1998. V. 2. №2. P. 275-281.
19. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/mice reveals a role for chemokines in the initiation of atherosclerosis // Nature. 1998. V. 394. №6696. P. 894-897.
20. Clinton S. K., Underwood R., Hayes L., Sherman M.L., Kufe D.W., Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis // The American journal of pathology. 1992. V. 140. №2. P. 301.
21. Rosenfeld M.E., Yla-Herttuala S., Lipton B.A., Ord V.A., Witztum J.L., Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans // The American journal of pathology. 1992. V. 140. №2. P. 291.
22. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., ... Lira S.A. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques // The Journal of clinical investigation. 2007. V. 117. №1. P. 185-194.
23. Libby P., Nahrendorf M., Pittet M.J., Swirski F.K. Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. 2008.
24. Swirski, F.K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F.W., Weissleder, R., & Pittet, M.J. Ly-6C hi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata // The Journal of clinical investigation. 2007. V. 117. №1. P. 195-205.
25. An G., Wang H., Tang R., Yago T., McDaniel J.M., McGee S., ... Xia L. PSGL-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice // Circulation. 2008. V. 117. №25. P. 3227.
26. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword // Nature reviews immunology. 2006. V. 6. №7. P. 508-519.
27. Hansson G. K. Inflammation, atherosclerosis, and coronary artery disease // New England Journal of Medicine. 2005. V. 352. №16. P 1685-1695.
28. Schulte S., Sukhova G.K., Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis // The American journal of pathology. 2008. V. 172. №6. P 1500-1508.
29. Mor A., Planer D., Luboshits G., Afek A., Metzger S., Chajek-Shaul T., ... George J. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis // Arteriosclerosis, thrombosis, and vascular biology. 2007. V. 27. №4. P. 893-900.
30. Han S.F., Liu P., Zhang W., Bu L., Shen M., Li H., ... Jia G.L. The opposite-direction modulation of CD4+ CD25+ Tregs and T helper 1 cells in acute coronary syndromes // Clinical immunology. 2007. V. 124. №1. P 90-97.
31. Palladino M.A., Bahjat F.R., Theodorakis E.A., Moldawer L.L. Anti-TNF-a therapies: the next generation // Nature reviews Drug discovery. 2003. V. 2. №9. P. 736-746.
32. Kume T., Okura H., Yamada R., Kawamoto T., Watanabe N., Neishi Y., ... Yoshida K.Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography // Circulation Journal. 2009. P
33. Kashiwagi M., Tanaka A., Kitabata H., Tsujioka H., Matsumoto H., Arita Y, ... Ikejima H. Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome // Circulation Journal. 2009. V. 73. №7. P 1291-1295.
34. Mach F., Sauty A., larossi A. S., Sukhova G.K., Neote K., Libby P., Luster A.D. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells // The Journal of clinical investigation. 1999. V. 104. №8. P 1041-1050.
35. Heller E.A., Liu E., Tager A.M., Yuan Q., Lin A.Y., Ahluwalia N., ... Moore K.J. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells // Circulation. 2006. V. 113. №19. P. 2301-2312.
36. Van Wanrooij E.J. A. et al. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice // Arteriosclerosis, thrombosis, and vascular biology. 2008. V. 28. №2. P. 251-257.
37. Mach F., Schonbeck U., Bonnefoy J.Y, Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor // Circulation. 1997. V. 96. №2. P. 396-399.
38. Mach F., Schonbeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober J.S., Libby P Functional CD 40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis // Proceedings of the National Academy of Sciences. 1997. V. 94. №5. P 1931-1936.
39. Amento E.P., Ehsani N., Palmer H., Libby P Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells // Arteriosclerosis and thrombosis: a journal of vascular biology. 1991. V. 11. №5. P 1223-1230.
40. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002 // Jama. 2004. V. 291. №23. P. 2847-2850.
41. Shiraishi J., Kohno Y., Sawada T., Nishizawa S., Arihara M., Hadase M., ... Shigeta M Relation of obesity to acute myocardial infarction in Japanese patients // Circulation Journal. 2006. V. 70. №12. P 1525-1530.
42. Чаулин А.М., Григорьева Ю.В., Дупляков Д.В. Участие катехоламинов в патогенезе диабетической кардиомиопатии // Медицина в Кузбассе. 2020. №1. С. 11-18.
43. Oda E. CRP may be superior to anthropometric markers of obesity //Circulation Journal. - 2006. V. 71. №8. P 1332-1333.
44. Чаулин А.М., Григорьева Ю.В., Дупляков Д.В. Коморбидность: хроническая обструктивная болезнь легких и сердечно-сосудистые заболевания // Практическая медицина. 2020. Т 18. №1. С. 26-31.
45. Maeda K., Okubo K., Shimomura I., Mizuno K., Matsuzawa Y., Matsubara K. Analysis of an expression profile of genes in the human adipose tissue // Gene. 1997. V. 190. №2. P. 227-235.
46. Rocha V.Z., Libby P. The multiple facets of the fat tissue // Thyroid. 2008. V. 18. №2. P. 175-183.
47. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation // New England journal of medicine. 1999. V. 340. №6. P. 448-454.
48. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? // Atherosclerosis. 2000. V. 148. №2. P. 209214.
49. Libby P., Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. 1999.
50. Lemieux I., Pascot A., Prud'homme D., Almdras N., Bogaty P., Nadeau A., ... Despres J.P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity // Arteriosclerosis, thrombosis, and vascular biology. 2001. V. 21. №6. P. 961-967.
51. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A. W. Obesity is associated with macrophage accumulation in adipose tissue // The Journal of clinical investigation. 2003. V. 112. №12. P 1796-1808.
52. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., ... Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance // The Journal of clinical investigation. 2003. V. 112. №12. P 1821-1830.
53. Wu H., Ghosh S., Perrard X.D., Feng L., Garcia G.E., Perrard J.L., ... Ballantyne C.M. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity // Circulation. 2007. V. 115. №8. P 1029.
54. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., ... Hauner H. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance // Arteriosclerosis, thrombosis, and vascular biology. 2008. V. 28. №7. P 1304-1310.
55. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., ... Mathis D. (Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters // Nature medicine. 2009. V. 15. №8. P. 930-939.
56. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., ... Yoshimura K. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity // Nature medicine. 2009. V. 15. №8. P. 914-920.
57. Rocha V.Z. et al. Interferon-y, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity // Circulation research. 2008. V. 103. №5. P. 467-476.
58. Hu E., Liang P., Spiegelman B.M. Adipo Q is a novel adipose-specific gene dysregulated in obesity // Journal of biological chemistry. 1996. V. 271. №18. P. 10697-10703.
59. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes // Journal of Biological chemistry. 1995. V. 270. №45. P 26746-26749.
60. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPoseMost abundant Gene transcript 1) // Biochemical and biophysical research communications. 1996. V. 221. №2. P 286-289.
61. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (Adipose Most Abundant Gene Transcript 1) (Reprinted from Biochemical and biophysical research communications, vol 221, pg 286-289, 1996) // Biochemical and biophysical research communications. 2012. V. 425. №3. P 556-559.
62. Shibata R., Ouchi N., Murohara T. Adiponectin and Cardiovascular Disease // Circulation Journal. 2009. V.73. №4. P. 608-614.
63. Arita Y, Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.I., ... Kuriyama H. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity // Biochemical and biophysical research communications. 1999. V. 257. №1. P 79-83.
64. Okamoto Y., Folco E.J., Minami M., Wara A.K., Feinberg M.W., Sukhova G.K., ... Libby P. Adiponectin: a key adipocytokine in metabolic syndrome // Clinical science. 2006. V. 110. №3. P 267-278.
65. Okamoto Y., Folco E.J., Minami M., Wara A.K., Feinberg M.W., Sukhova G.K., ... Libby P inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis // Circulation research. 2008. V. 102. №2. P 218-225.
66. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles J.S., Gotto Jr A. M. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events // New England Journal of Medicine. 2001. V. 344. №26. P 1959-1965.
67. Ridker P.M., Cook N.R. Statins: new American guidelines for prevention of
cardiovascular disease // The Lancet. 2013. V. 382. №9907. P 1762-1765.
68. Glynn R.J., Danielson E., Fonseca F.A., Genest J., Gotto Jr A.M., Kastelein J.J., ... Nordestgaard B.G. A randomized trial of rosuvastatin in the prevention of venous thromboembolism // New England Journal of Medicine. 2009. V. 360. №18. P 1851-1861.
References
1. Libby, P. (2002). Atherosclerosis: the new view. Scientific American, 286(5), 46-55.
2. Chaulin, A., Karslyan, L., Aleksandrov, A., Mazaev, A., Grigorieva, E., & Nurbaltaeva, D. (2019). The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Atherosclerosis Development. Bulletin of Science and Practice, 5(5), 112-120. (in Russian).
3. Chaulin, A.M., Karslyan, L.S., Bazyuk, E.V., Nurbaltaeva, D.A., & Duplyakov, D.V. (2019). Clinical and Diagnostic Value of Cardiac Markers in Human Biological Fluids. Kardiologiia, 59(11). 66-75. (in Russian).
4. Chaulin, A.M., & Duplyakov, D.V. (2020). MicroRNAs in Atrial Fibrillation: Pathophysiological Aspects and Potential Biomarkers. International Journal of Biomedicine, 10(3), 198-205.
5. Chaulin, A.M., Grigoryeva, Y.V., & Duplyakov, D.V. (2020). Comboridity of chronic obstructive pulmonary disease and cardiovascular diseases: general factors, pathophysiological mechanisms and clinical significance. Journal of Clinical Practice, 11(1), 112-121. (in Russian).
6. Chaulin, A.M., & Duplyakov, D.V. (2019). Increased cardiac troponins, not associated with acute coronary syndrome. Part 1. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training], 7(2), 13-23. (in Russian).
7. Chaulin, A.M., Grigoryeva, Yu.V., & Duplyakov, D.V. (2020). Modern views about the pathophysiology of atherosclerosis. part 1. the role of impaired lipid metabolism and endothelial dysfunction (literature review). Medicine in Kuzbass, 19(2), 34-41.
8. Chaulin, A.M. (2020). The involvement proprotein convertase subtilisin/kexin of type 9 in the pathogenesis of atherosclerosis (literature review). University proceedings. Volga region. Medical sciences, (1(53)), 111-128.
9. Chaulin, A.M., Duplyakov, D.V. (2019). PCSK-9: modern views about biological role and possibilities of use as a diagnostic marker for cardiovascular diseases. Part 1. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training], 7(2), 45-57. (in Russian).
10. Chaulin, A.M., & Duplyakov, D.V. (2019). PCSK-9: modern views about biological role and possibilities of use as a diagnostic marker for cardiovascular diseases. Part 2. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training], 7(4), 24-35. (in Russian).
11. Chaulin, A.M., Grigoreva, Yu.V., Suvorova, G.N., & Duplyakov, D.V. (2020). Methods for modeling atherosclerosis in rabbits. Modern problems of science and education, (5).
12. Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868-874.
13. Libby, P., Ridker, P M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105(9), 1135-1143.
14. Mestas, J., & Ley, K. (2008). Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends in cardiovascular medicine, 18(6), 228-232.
15. Rader, D.J., & Daugherty, A. (2008). Translating molecular discoveries into new therapies for atherosclerosis. Nature, 451(7181), 904-913.
16. Cybulsky, M.I., & Gimbrone, M.A. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 251(4995), 788-791.
17. Li, H., Cybulsky, M.I., Gimbrone Jr, M.A., & Libby, P (1993). Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. The American journal of pathology, 143(6), 1551-1559.
18. Gu, L, Okada, Y, Clinton, S.K., & al. (1998). Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell., 2(2), 275-281.
19. Boring, L., Gosling, J., Cleary, M., & Charo, I.F. (1998). Decreased lesion formation in CCR2-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 394(6696), 894-897.
20. Clinton, S.K., Underwood, R., Hayes, L., Sherman, M.L., Kufe, D.W., & Libby, P. (1992). Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. The American journal of pathology, 140(2), 301.
21. Rosenfeld, M.E., Yla-Herttuala, S., Lipton, B.A., Ord, V.A., Witztum, J.L., & Steinberg, D. (1992). Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. The American journal of pathology, 140(2), 291.
22. Tacke, F., Alvarez, D., Kaplan, T.J., Jakubzick, C., Spanbroek, R., Llodra, J., ..., & Lira, S.A. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. The Journal of clinical investigation, 117(1), 185-194.
23. Libby, P., Nahrendorf, M., Pittet, M.J., & Swirski, F.K. (2008). Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal.
24. Swirski, F.K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F.W., Weissleder, R., & Pittet, M.J. (2007). Ly-6C hi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. The Journal of clinical investigation, 117(1), 195-205.
25. An, G., Wang, H., Tang, R., Yago, T., McDaniel, J.M., McGee, S., ..., & Xia, L. (2008). PSGL-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation, 117(25), 3227.
26. Hansson, G.K., & Libby, P (2006). The immune response in atherosclerosis: a doubleedged sword. Nature reviews immunology, 6(7), 508-519.
27. Hansson, G.K. (2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 552(16), 1685-1695.
28. Schulte, S., Sukhova, G.K., & Libby, P (2008). Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. The American journal of pathology, 172(6), 1500-1508.
29. Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T., ..., & George, J. (2007). Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 27(4), 893-900.
30. Han, S.F., Liu, P., Zhang, W., Bu, L., Shen, M., Li, H., ..., & Jia, G.L. (2007). The opposite-direction modulation of CD4+ CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clinical immunology, 124(1), 90-97.
31. Palladino, M.A., Bahjat, F.R., Theodorakis, E.A., & Moldawer, L.L. (2003). Anti-TNFa therapies: the next generation. Nature reviews Drug discovery, 2(9), 736-746.
32. Kume, T., Okura, H., Yamada, R., Kawamoto, T., Watanabe, N., Neishi, Y., ..., & Yoshida, K. (2009). Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography. Circulation Journal
33. Kashiwagi, M., Tanaka, A., Kitabata, H., Tsujioka, H., Matsumoto, H., Arita, Y., ..., & Ikejima, H. (2009). Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome. Circulation Journal, 73(7), 1291-1295.
34. Mach, F., Sauty, A., Iarossi, A.S., Sukhova, G.K., Neote, K., Libby, P., & Luster, A.D. (1999). Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. The Journal of clinical investigation, 104(8), 1041-1050.
35. Heller, E.A., Liu, E., Tager, A.M., Yuan, Q., Lin, A.Y., Ahluwalia, N., ..., & Moore, K.J. (2006). Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation, 113(19), 2301-2312.
36. Van Wanrooij, E.J., de Jager, S.C., van Es, T., de Vos, P., Birch, H.L., Owen, D.A., ..., & Kuiper, J. (2008). CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 28(2), 251-257.
37. Mach, F., Schonbeck, U., Bonnefoy, J.Y., Pober, J.S., & Libby, P. (1997). Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 96(2), 396-399.